Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

One Of The Top Rehab Centers in Orange County California Implements Naltrexone Implants To Improve Long Term Recovery Success Rate
  • USA - English


News provided by

Knack Media

May 03, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Broadway Treatment Center
Broadway Treatment Center
Youtube
Youtube

Our job is to keep you or your loved one comfortable and motivated throughout the journey to recovery. Call now (714) 443-8218

Post this

Huntington Beach, California (PRWEB) May 03, 2016 -- Broadway Treatment Center has introduced Naltrexone Therapy to their growing portfolio of services they offer their clients. Naltrexone can be administered orally, injected, or through an implant. Oral medication can often be forgotten, so Broadway is offering the implant version. The Naltrexone implant has been proven to dramatically decrease the relapse rate of people in recovery from opiates and/or alcohol. Naltrexone blocks the opiate receptors in the recovering addict’s brain, in turn, dramatically reducing cravings. It is a non-addictive medication and will not block the body’s natural endorphins. If a person does happen to relapse, Naltrexone will prevent the person from feeling high. For information about Naltrexone implants contact the office and speak with a professional adviser here, (714) 443-8218.

The freedom from intense cravings and the inability to become high is what helps people in recovery get through those challenging first months in recovery. Naltrexone will alleviate these physical symptoms and allow the person to focus on the emotional and psychological aspects of their sobriety. The Naltrexone pellet is implanted just under the person’s skin in a painless procedure. The implant will slowly release a dose of medication over the next two months and provide extra physical support.

Broadway recommends that their clients continue their Naltrexone therapy for at least a year following completion of their monitored withdrawal detox program. This will ensure they have had time to develop new, healthy habits, and a healthy mindset surrounding their addiction. Naltrexone has showed no ill side-effects and has dramatically increased the success rate of staying sober after recovery. The naltrexone implant is a valuable comfort measure that makes the transition to recovery easier and more likely to last.

Broadway Treatment Centers is one of the fastest growing substance abuse recovery centers in Southern California. The Orange County substance abuse treatment facility has expanded by over 200 % since their start in 2012, and are continuing to grow. Their multidisciplinary approach to addiction recovery is ever expanding with newly added therapies and constantly improving technologies. The addition of naltrexone therapy is part of their larger goal of being able to provide multiple comfort options to their clients.

Broadway currently offers many unique modalities to fit the needs of their clients. Many different therapy options such as Sand Tray Therapy, IV Vitamin Therapy, Music and Art Therapy, Yoga Therapy, Equine Therapy, Trauma Therapy, and Surfing. In addition to the wide array of therapies, Broadway also offers Nexalin as a holistic alternative to medication therapies. Nexalin Therapy uses cutting edge, non-invasive, brainwave technology to reset the brain. The Nexalin device uses harmless waves to stimulate the hypothalamus and mid-brain, resetting their function to a normal level. The effects are shown to be long term and a great alternative to medication.

Broadway Treatment Centers was one of the pioneers in the pet friendly addiction treatment movement. They were one of the first treatment centers to allow pets to accompany their clients to rehabilitation. It has been proven that animals are very beneficial in a therapeutic capacity during addiction treatment. The relationship between pet and owner offers a great source of comfort and reassurance while in recovery. The love and support a pet gives a client is unwavering, and many times that is what is needed to make it through the first few weeks of addiction recovery, which prove to be some of the toughest.

Broadway Treatment Centers also provides couples addiction treatment. A dynamic approach of treating the individual along with the couple has proven to help both people successfully recover. Broadway addresses and works through many factors that will make it possible for a couple to fully recover and successfully achieve long term sobriety. Broadway will work closely with both parties in the relationship to really get to know their needs and wants, and what they envision for their relationship in recovery. Broadway offers many different types of addiction treatment plans within the modalities of Couples Rehabilitation. There is sure to be something for everyone. For more information about one of the best rehabs in Orange County contact the number listed.

Phone: (714) 443 8218
Contact: http://broadwaytreatmentcenter.com/contact-us/

Mason Baxter, Knack Media, http://www.knackmedia.com, +1 (877) 957-2244, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.